Clinical RoundupFree FDA finds survival deficit in some patients taking Keytruda or Tecentriq as monotherapy in urothelial cancer with low expression of PD-L1 May 18, 2018Vol.44 No.20
Clinical RoundupFree Tecentriq and Avastin plus carboplatin and paclitaxel show longer remissions vs. Avastin plus carboplatin and paclitaxel in metastatic NSCLC May 18, 2018Vol.44 No.20
Clinical RoundupFree Bone scan software calculates prognosis of advanced prostate cancer May 18, 2018Vol.44 No.20
Clinical Roundup Phase III trial of Lonsurf in gastric cancer produces positive topline result May 11, 2018Vol.44 No.19
Clinical Roundup ONS: Nurse navigators play crucial role in patient outcomes May 11, 2018Vol.44 No.19
Clinical RoundupFree Keytruda meets ORR endpoint in interim analysis of phase III trial in NSCLC May 04, 2018Vol.44 No.18
Clinical RoundupFree TESARO announces positive top-line results from Quadra trial of Zejula April 27, 2018Vol.44 No.17
Clinical RoundupFree Keytruda combination improved OS regardless of PD-L1 expression, including patients who tested negative for PD-L1 April 20, 2018Vol.44 No.16
Clinical RoundupFree Keytruda reduced risk of recurrence or death by over 40% vs. placebo as adjuvant therapy in resected, high-risk stage III melanoma April 20, 2018Vol.44 No.16
